Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
6 results
  • Thyroid Cancer

19-896          Phase III

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib (LOXO-292) to Physicians Choice of Cabozantinib or Vandetanib in Patients with Progressive, Advanced, Kinase Inhibitor Naive, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531) (View details on clinicaltrial.gov)

  • Lung Cancer, Thyroid Cancer, Brain Tumors, Melanoma

20-200          Phase I

A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations (View details on clinicaltrial.gov)

  • Lung Cancer, Thyroid Cancer, Head and Neck Cancer

17-241          Phase I

A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001) (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Thyroid Cancer, Lung Cancer, Sarcoma

17-481          Phase II

A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Thyroid Cancer, Lung Cancer

19-804          Phase II

A phase 1/2 study of TPX-0046,a novel oral RET/SRC inhibitor in adult subjects with advanced/metastatic solid tumors harboring oncogenic RET fusions or mutations (View details on clinicaltrial.gov)

Showing 1 - 10 of 6 results